The Genetic Cancer Risk in the Young (RisC) Study aims to understand more about genetic variants that contribute to inherited cancers by utilising whole genome sequencing to identify the number of clinically actionable variants in a cohort of patients with either a young onset cancer diagnosis and/or multiple primary cancers, which are suggestive of genetic aetiology. A greater understanding of these genetic variants will lead to improved cancer risk management and prevention, improved surveillance for early detection of new cancers, and better personalised cancer treatment and outcomes, for these individuals.
For further information regarding the RisC Study at the Peter MacCallum Cancer Centre, including full inclusion/exclusion criteria and patient referrals, please contact the Victorian RisC Study Coordinator.
Funding
Australian Genomic Cancer Medicine Program
Peter MacCallum Cancer Centre Principal Investigator
Professor Paul James
Contact details
Ms Elisa Cops, Victorian RisC Study Coordinator
- Email:
This email address is being protected from spambots. You need JavaScript enabled to view it. - Phone: (03) 8559 5327 / (03) 8559 5322
Project group
Familial Cancer Research Centre
Project status
Ongoing